We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
53 hedge funds and large institutions have $8.81M invested in Cardiff Oncology in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
2.37% less ownership
Funds ownership: 15.78% → 13.41% (-2.4%)
4% less funds holding
Funds holding: 55 → 53 (-2)
24% less capital invested
Capital invested by funds: $11.6M → $8.81M (-$2.83M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
74% less call options, than puts
Call options by funds: $34K | Put options by funds: $129K
Holders
53
Holders Change
-2
Holders Change %
-3.64%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
9
Closed
5
Calls
$34K
Puts
$129K
Net Calls
-$95K
Net Calls Change
+$119K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$128K |
| 2 |
Two Sigma Investments
New York
|
+$102K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$89.6K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$53.6K |
| 5 |
Two Sigma Advisers
New York
|
+$47.3K |
Top Sellers
| 1 |
Citigroup
New York
|
-$1.07M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$407K |
| 3 |
Morgan Stanley
New York
|
-$303K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$158K |
| 5 |
Millennium Management
New York
|
-$89K |
